Researchers at Northeastern say they’ve discovered how an antibody could provide broad protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19—even as it evolves to outwit other of the body’s …
B-cells protect your body from infection. But sometimes, they misfire and cause debilitating disease. Now, University of Connecticut researchers have shown that a single protein might be able to defuse B-cells gone bad. Their findings are published in …
The answer to curbing influenza could be right under our noses—or, more accurately, inside them. New research maps happenings in the nose during the course of influenza in exquisite detail, and could potentially lead to new targets and more effective n…
A new study published in eLife by researchers from the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz Medical Campus reports the initial results of a first-in-kind clinical trial testing the safety and …
Mosquito saliva is known to play a significant role in the transmission of viruses such as yellow fever, Zika, dengue, and chikungunya, yet many of its functions have yet to be understood. In a new study, researchers revealed that a mosquito salivary p…
Respiratory infections can be severe—even deadly—in some individuals, but not in others. Scientists at St. Jude Children’s Research Hospital, the Peter Doherty Institute for Infection and Immunity and other collaborators have gained new understanding o…
More than half of us are carriers of chronic herpesvirus infections.
Researchers at the University of Liège (Belgium) have discovered a new population of macrophages, important innate immune cells that populate the lungs after injury caused by respiratory viruses. These macrophages are instrumental in repairing the pulm…
A research group led by Kyoto University has produced the world’s first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.
The University of Queensland-led and developed COVID-19 Risk Calculator has been updated to determine a person’s risk of developing long COVID.
